Privately held Qu Biologics Inc, Vancouver, has closed a private equity financing of $3.5 million, bringing its total raised to $19 million. The investors in the developer of site specific immunohematologys was not disclosed....
By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively
in accordance with our Privacy Policy and Terms of Service.